garenoxacin has been researched along with remoxipride in 1 studies
| Studies (garenoxacin) | Trials (garenoxacin) | Recent Studies (post-2010) (garenoxacin) | Studies (remoxipride) | Trials (remoxipride) | Recent Studies (post-2010) (remoxipride) |
|---|---|---|---|---|---|
| 195 | 19 | 46 | 272 | 65 | 21 |
| Protein | Taxonomy | garenoxacin (IC50) | remoxipride (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.4406 | |
| D(4) dopamine receptor | Homo sapiens (human) | 3.872 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 1.57 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evans, CA; Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
1 other study(ies) available for garenoxacin and remoxipride
| Article | Year |
|---|---|
Extrapolation of preclinical pharmacokinetics and molecular feature analysis of "discovery-like" molecules to predict human pharmacokinetics.
Topics: Animals; Biometry; Dogs; Drug Evaluation, Preclinical; Haloperidol; Haplorhini; Humans; Injections, Intravenous; Liver; Liver Circulation; Metabolic Clearance Rate; Mifepristone; Molecular Structure; Molecular Weight; Rats; Reproducibility of Results | 2006 |